CDH2 and glioblastoma: Further evaluation through Western blot analysis of the factors inhibiting GBM cell migration and invasion post-RSV treatment indicated significant diminution in mesenchymal protein expression levels (N-cadherin, Vimentin, and MMP-3) and a suggestive upregulation of epithelial markers (E-cadherin) as opposed to control samples (Fig. 1I).